VenetoclaxClinical tumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35548-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：408 / 408

相关论文

共 50 条

[31] Cisplatin/fluorouracilClinical tumour lysis syndrome and nephrotoxicity: case report
Reactions Weekly, 2022, 1904 (1) : 149 - 149
[32] Etoposide/ibrutinibLiver toxicity and tumour lysis syndrome: case report
Reactions Weekly, 2020, 1829 (1) : 175 - 175
[33] Multiple drugsLack of efficacy and tumour lysis syndrome: case report
Reactions Weekly, 2024, 2036 (1) : 316 - 316
[34] Carboplatin/etoposide/ifosfamideChoriocarcinoma syndrome and tumour lysis: case report
Reactions Weekly, 2021, 1871 (1) : 112 - 112
[35] Doxorubicin/ifosfamideLack of efficacy and tumour lysis syndrome: case report
Reactions Weekly, 2023, 1940 (1) : 172 - 172
[36] Multiple drugsTreatment failure and tumour lysis syndrome: case report
Reactions Weekly, 2021, 1836 (1) : 557 - 557
[37] Cyclophosphamide/doxorubicin/vincristineFatal tumour lysis syndrome: case report
Reactions Weekly, 2011, 1377 (1) : 15 - 15
[38] Antineoplastics/furosemideLack of efficacy and tumour lysis syndrome: case report
Reactions Weekly, 2023, 1971 (1) : 39 - 39
[39] AntineoplasticsDisseminated intravascular coagulopathy and tumour lysis syndrome: case report
Reactions Weekly, 2021, 1874 (1) : 30 - 30
[40] CarfilzomibAcute kidney injury and tumour lysis syndrome: case report
Reactions Weekly, 2021, 1837 (1) : 139 - 139

← 1 2 3 4 5 →